According to the data described in this narrative review, the reinforcement of the endogenous EPO/EPOR system by exogenous EPO molecules may be crucial in protecting the brain against neurological damage caused by abnormal Aβ and tau-p aggregates or other pathological stimuli that promote the neurodegeneration in AD (Figure 5). This evidence concerns the gene MAPT and Alzheimer disease.